What is Chugai Pharmaceutical Co Price-to-Operating-Cash-Flow?
As of today (2024-04-26), Chugai Pharmaceutical Co's share price is $32.43.
Chugai Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.61. Hence, Chugai Pharmaceutical Co's Price-to-Operating-Cash-Flow Ratio for today is 20.18.
The historical rank and industry rank for Chugai Pharmaceutical Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
CHGCF'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 13.27 Med: 30.03 Max: 56.77
Current: 20.68
During the past 13 years, Chugai Pharmaceutical Co's highest Price-to-Operating-Cash-Flow Ratio was 56.77. The lowest was 13.27. And the median was 30.03.
Chugai Pharmaceutical Co's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was $0.52.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.61.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Chugai Pharmaceutical Co was 68.30% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 26.00% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 22.10% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 26.80% per year.
During the past 13 years, Chugai Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 74.50% per year. The lowest was -36.20% per year. And the median was 18.90% per year.
Chugai Pharmaceutical Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Chugai Pharmaceutical Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chugai Pharmaceutical Co Price-to-Operating-Cash-Flow Chart
|
Chugai Pharmaceutical Co Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
26.74 |
44.15 |
21.97 |
22.75 |
21.44 |
|
Chugai Pharmaceutical Co Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
18.01 |
26.61 |
29.41 |
21.44 |
- |
Competitive Comparison of Chugai Pharmaceutical Co's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chugai Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Chugai Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.
Chugai Pharmaceutical Co Price-to-Operating-Cash-Flow Calculation
Chugai Pharmaceutical Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 32.43 | / | 1.607 |
| = | 20.18 |
Chugai Pharmaceutical Co's Share Price of today is $32.43.
Chugai Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.61.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Chugai Pharmaceutical Co (Chugai Pharmaceutical Co) Business Description
Traded in Other Exchanges
Address
1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding Ltd, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and tocilizumab for treating rheumatoid arthritis and COVID-19.
Chugai Pharmaceutical Co (Chugai Pharmaceutical Co) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CHGCF has been successfully added to your